Document ID: chunk:federal_register_of_legislation:F2022C00577:front:0:p6
Version: federal_register_of_legislation:F2022C00577
Segment Type: other
Provision Reference: 
Character Range: 14308–17562

single functional ovary or testis, where there is only one functional ovary or testis;
before the clinical worsening of hypogonadism;
(44)      undergoing a course of therapeutic radiation for cancer, where:
(a)          both ovaries or testes; or
(b)          a single functional ovary or testis, where there is only one functional ovary or testis;
were in the field of radiation before the clinical worsening of hypogonadism;
(45)      having infection with human immunodeficiency virus before the clinical worsening of hypogonadism;
(46)      having infection with Mycobacterium leprae before the clinical worsening of hypogonadism;
            Note: Mycobacterium leprae is the organism that causes leprosy.
(47)      having infection with Trypanosoma brucei before the clinical worsening of hypogonadism;
            Note: Trypanosoma brucei is the organism that causes African sleeping sickness (trypanosomiasis).
(48)      having mumps orchitis as an adult affecting:
(a)          both testes; or
(b)          a single functional testis, where there is only one functional testis;
before the clinical worsening of hypogonadism;
(49)      for males only, having rheumatoid arthritis or granulomatosis with polyangiitis before the clinical worsening of hypogonadism;
(50)      having Addison disease before the clinical worsening of hypogonadism;
(51)      having an infiltrative disease from the specified list of infiltrative diseases of:
(a)          both ovaries or testes; or
(b)          a single functional ovary or testis, where there is only one functional ovary or testis;
before the clinical worsening of hypogonadism;
            Note: specified list of infiltrative diseases is defined in the Schedule 1 - Dictionary.
(52)      for males only, having a testicular varicocoele before the clinical worsening of hypogonadism;
(53)      having infarction of:
(a)          both ovaries or testes; or
(b)          a single functional ovary or testis, where there is only one functional ovary or testis;
within the 1 year before the clinical worsening of hypogonadism;
(54)      having sickle-cell disorder before the clinical worsening of hypogonadism;
(55)      having a bone marrow or stem cell transplant before the clinical worsening of hypogonadism;
(56)      having cirrhosis of the liver at time of the clinical worsening of hypogonadism;
(57)      having chronic kidney disease at time of the clinical worsening of hypogonadism;
            Note: chronic kidney disease is defined in the Schedule 1 - Dictionary.
(58)      having anorexia nervosa at the time of the clinical worsening of hypogonadism;
(59)      taking a course of systemic cytotoxic drugs for treatment of a malignant neoplasm before the clinical worsening of hypogonadism;
(60)      taking gonadotrophin releasing hormone agonists or antagonists as androgen or estrogen deprivation therapy for at least 1 year within the 2 years before the clinical worsening of hypogonadism;
(61)      having active epilepsy before the clinical worsening of hypogonadism;
            Note: active epilepsy is defined in the Schedule 1 - Dictionary.
(62)      taking a drug from the Specified List 1 of drugs before the clinical worsening of hypogonadism;
            Note: Specified